Text Size

Optimizing the Effect of COPD Rehabilitation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Glostrup University Hospital, Copenhagen.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Ministry of the Interior and Health, Denmark
Information provided by:
Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT00419289
First received: January 4, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
  Purpose

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.


Condition Intervention
Chronic Obstructive Pulmonary Disease
 Behavioral: follow-up rehabilitation of participants with COPD

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Glostrup University Hospital, Copenhagen:

Primary Outcome Measures:
  • Disease specific Quality of Life
  • Work Capacity

Secondary Outcome Measures:
  • Number of days admitted to hospital

Estimated Enrollment: 120
Study Start Date: January 2007
Estimated Study Completion Date: June 2008
Detailed Description:

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • FEV1 < 60% of expected

Exclusion Criteria:

  • Other severe chronic conditions
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00419289

Contacts
Contact: Susanne Vest, MD susanne.vest@dadlnet.dk
Contact: Allan Linneberg, MD alli@glostruphosp.kbhamt.dk

Locations
Denmark
Department of Internal Medicine M, Glostrup University Hospital Not yet recruiting
Copenhagen, Denmark, 2600
Contact: Susanne Vest, MD         susanne.vest@dadlnet.dk    
Principal Investigator: Susanne Vest, MD            
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
Ministry of the Interior and Health, Denmark
Investigators
Principal Investigator: Susanne Vest, MD Glostrup University Hospital, Copenhagen
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00419289     History of Changes
Other Study ID Numbers: KA20060179
Study First Received: January 4, 2007
Last Updated: January 4, 2007
Health Authority: Denmark: Ethics Committee

Keywords provided by Glostrup University Hospital, Copenhagen:
COPD, rehabilitation, quality of life

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 16, 2013